Last updated: 2026-09-16 09:46:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AirSculpt Technologies, Inc. (AIRS) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NASDAQ. The stock is currently priced at $2.10, with a market capitalisation of $171.59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.51 to $12.00. This page covers its latest market performance, valuation, price trends and company information.
$171.59M | |
$2.10 | |
$18.48 | |
$1.51 | |
$2.13 | |
144.00 | |
732.26K | |
-- | |
$12.00 | |
$1.51 | |
-- | |
-- |
AirSculpt Technologies, Inc. (AIRS) is trading at $2.10 in pre-market trading as of 2026-09-16 09:02:00, down 1.41% ($0.03) from the previous close of $2.13
Pre-market trading shows how investors are pricing AIRS before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, AirSculpt Technologies, Inc. (AIRS) moved from $2.80 to $2.10, representing a decline of 24.87% ($0.69).
The stock traded between $2.10 and $3.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.07 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 5.6%
AIRS is currently trading at $2.10, placing it 5.6% of the way from its 52-week low of $1.51 to its 52-week high of $12.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 363 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AirSculpt Technologies, Inc. (AIRS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.